News

Dance Competition 'Dance your PhD' at IMP

Scientists from various disciplines were given the chance to interpret the title of their doctoral thesis into a form of...

Vaccine formulated with Intercell's adjuvant IC31 part of a broader collaboration to fight Tuberculosis

Vaccine formulated with Intercell's adjuvant IC31 part of a broader collaboration to fight Tuberculosis

» TB-vaccine...

Medical University of Vienna and emergentec: Ovarian cancer - systems biology goes clinic

A team based in Vienna has established a time-saving and efficient strategy for identifying important protein structures...

Intercell's therapeutic Hepatitis C vaccine meets primary endpoints in Phase II

Intercell's therapeutic Hepatitis C vaccine meets primary endpoints in Phase II

» Data from 50 patients reveal...

Agnes Streissler as new representative of ZIT in LISA VR's advisory board

With immediate effect Agnes Streissler represents ZIT in LISA VR’s advisory board. Since October 2007 she heads the...

IMP: Molecular Glue with New Effect

IMP: Molecular Glue with New Effect

Researchers at the Institute of Molecular Pathology (IMP)

in Vienna clarify cause...

Sanochemia: Final results for 2006/2007 fiscal year

Sanochemia: Final results for 2006/2007 fiscal year Sales revenues increase by 6% in core segments – one-off impairment...

AAS: Novartis Research Prize for Karel Riha

Karel Riha, a Young Investigator at the GMI, has been awarded the 2007 Novartis Research Prize in Biology. The Novartis...

Intercell (ICLL) and the PATH malaria vaccine initiative announce new collaboration for a vaccine against m...

Intercell (ICLL) and the PATH malaria vaccine initiative announce new collaboration for a vaccine against malaria

Intercell receives manufacturer's licence for future commercial manufacturing of its vaccine against Japane...

Intercell receives manufacturer's licence for future commercial manufacturing of its vaccine against Japanese...

60th anniversary of Boehringer Ingelheim in Austria

60th anniversary of Boehringer Ingelheim in Austria

>> High-ranking politicians highlight the company’s importance for...

Intercell's results on a novel pneumococcal protein-based vaccine published in the Journal of Experimental ...

Intercell's results on a novel pneumococcal protein-based vaccine published in the Journal of Experimental Medicine

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on then-current expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? Just send your contributions to news(at)lisavienna.at.